YFR032C-B Antibody

Shipped with Ice Packs
In Stock

Description

Overview of YFR032C-B Antibody

YFR032C-B Antibody (Product Code: CSB-PA844760XA01SVG) is a polyclonal antibody designed to detect the YFR032C-B protein, a hypothetical ORF in Saccharomyces cerevisiae. This antibody is utilized primarily in molecular biology research to study gene expression, protein localization, and functional characterization in yeast models .

Applications:

  • Functional genomics: Linking YFR032C-B to metabolic or regulatory networks.

  • Comparative studies: Analyzing evolutionary conservation across fungal species.

Limitations:

  • Limited characterization: The biological role of YFR032C-B remains undefined, requiring further knockout or overexpression studies.

  • Commercial specificity: Independent validation (e.g., via siRNA knockdown) is recommended to confirm antibody specificity.

Broader Implications in Antibody Therapeutics

While YFR032C-B is a research tool, its development aligns with trends in precision antibody design, such as:

  • Convergent motifs: Structural motifs like YYDRxG (identified in SARS-CoV-2 antibodies ) enhance cross-reactivity, a principle applicable to yeast studies.

  • Database integration: Resources like YAbS track therapeutic antibodies, though YFR032C-B is not listed as a clinical candidate.

Future Directions

  • Functional annotation: High-throughput screens to identify YFR032C-B’s role in yeast biology.

  • Engineering: Adopting phage display or single-cell cloning to improve affinity.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YFR032C-B; Uncharacterized protein YFR032C-B
Target Names
YFR032C-B
Uniprot No.

Target Background

Database Links
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What are the primary applications for YFR032C-B antibodies in yeast research?

YFR032C-B antibodies are primarily utilized in several fundamental research applications including Western blotting (immunoblotting), immunoprecipitation (IP), immunofluorescence microscopy, and chromatin immunoprecipitation (ChIP-Seq). These antibodies enable researchers to study retrotransposon expression, localization, and interactions with other cellular components. The most common application involves co-immunoprecipitation (Co-IP) experiments to investigate protein-protein interactions involving YFR032C-B-encoded proteins . When designing experiments, researchers should consider that these antibodies recognize specific epitopes of the retrotransposon protein, allowing for purification and enrichment of the target protein from complex cellular lysates.

How should I validate the specificity of a YFR032C-B antibody before experimental use?

Validation of YFR032C-B antibody specificity requires a multi-step approach:

  • Western blot analysis using wild-type yeast and YFR032C-B deletion (yfr032c-bΔ) strains to confirm the antibody detects a band of the expected molecular weight in wild-type but not in knockout samples

  • Immunoprecipitation followed by mass spectrometry to confirm the captured protein is indeed YFR032C-B

  • Testing cross-reactivity against related retrotransposon proteins

  • Pre-absorption tests with purified antigen to demonstrate specific binding

A proper validation should include appropriate controls in each experiment, such as isotype controls (IgG from the same species) to exclude non-specific binding . Document the validation process thoroughly as this information will be critical for publication peer review.

What sample preparation techniques are most effective when working with YFR032C-B antibodies?

Optimal sample preparation for YFR032C-B antibody applications requires:

  • Lysis buffer selection: Use buffers containing mild detergents (0.5% NP-40 or 1% Triton X-100) supplemented with protease inhibitors to maintain protein integrity

  • Cell disruption method: For yeast cells, mechanical disruption with glass beads is recommended to efficiently break the cell wall

  • Pre-clearing step: This critical step reduces non-specific binding by incubating the lysate with protein A/G beads prior to immunoprecipitation

  • Sample storage: Store lysates at -80°C with glycerol (10-15%) to maintain protein stability and prevent degradation

The effectiveness of these preparations can be verified by running Western blots on the input samples before proceeding with immunoprecipitation or other applications. This ensures that the target protein is present and intact in your starting material.

How can I optimize co-immunoprecipitation conditions to detect transient or weak interactions with YFR032C-B protein?

Detecting transient or weak protein interactions with YFR032C-B requires several optimization strategies:

  • Crosslinking agents: Use reversible crosslinkers such as DSP (dithiobis(succinimidyl propionate)) at 0.5-2mM concentration to stabilize transient interactions

  • Buffer modifications: Reduce salt concentration (50-100mM NaCl) to preserve weak ionic interactions

  • Detergent selection: Use milder detergents (0.1% digitonin) instead of stronger ones (Triton X-100)

  • Incubation conditions: Perform binding steps at 4°C for longer periods (3-4 hours or overnight)

  • Bead optimization: Test different types of beads (agarose vs. magnetic) for improved capture efficiency

A systematic comparison of results obtained under different conditions should be performed, documenting protein recovery through quantitative Western blot analysis. This optimization process is especially important for YFR032C-B, as retrotransposon proteins often form complex interaction networks that can be disrupted under harsh experimental conditions.

What strategies can address non-specific binding issues when using YFR032C-B antibodies in co-immunoprecipitation?

Non-specific binding is a common challenge in co-immunoprecipitation experiments. When working with YFR032C-B antibodies, implement these specific strategies:

  • Pre-clearing optimization: Extend the pre-clearing step to 2 hours with protein A/G beads to remove proteins that bind non-specifically to the beads

  • Blocking agents: Add 1-5% BSA or 5% non-fat dry milk to blocking solutions to reduce non-specific interactions

  • Wash optimization: Develop a gradient washing protocol with increasing stringency (increasing salt concentration from 150mM to 300mM NaCl)

  • Control antibodies: Always include isotype-matched control IgG in parallel experiments to identify non-specific interactions

  • Alternative approach: Consider using epitope-tagged YFR032C-B constructs when native antibodies show high background

Data analysis should involve comparing immunoprecipitated proteins between experimental and IgG control samples, considering only those proteins enriched at least 3-fold in the experimental condition as potential true interactors.

How can I quantitatively analyze YFR032C-B protein-protein interactions across different experimental conditions?

Quantitative analysis of YFR032C-B protein interactions requires:

  • Input normalization: Standardize input protein concentrations across all experimental conditions

  • Internal standards: Include spike-in controls of known concentration for quantitative Western blot calibration

  • Densitometry analysis: Use software like ImageJ with appropriate background subtraction to quantify band intensities

  • Interaction ratio calculation: Calculate the ratio of co-immunoprecipitated protein to immunoprecipitated YFR032C-B

  • Statistical validation: Perform at least three biological replicates and apply appropriate statistical tests

Results can be presented in a data table format showing:

Experimental ConditionYFR032C-B Recovery (%)Interacting Protein Recovery (%)Interaction Ratiop-value
Standard condition1001001.0-
Condition Avaluevaluevaluevalue
Condition Bvaluevaluevaluevalue

This quantitative approach enables robust comparison between experimental conditions and evaluation of factors affecting interaction strength.

What is the optimal immunoprecipitation protocol for studying YFR032C-B interactions in yeast cells?

The optimal immunoprecipitation protocol for YFR032C-B studies involves:

  • Cell preparation: Grow yeast cells to mid-log phase (OD600 of 0.7-1.0) in appropriate media

  • Lysis procedure:

    • Harvest cells by centrifugation (3000g, 5 minutes, 4°C)

    • Wash twice with ice-cold PBS

    • Resuspend in lysis buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 0.5% NP-40, 1mM EDTA, protease inhibitor cocktail)

    • Disrupt cells with glass beads using a bead beater (5 cycles of 30 seconds on/30 seconds off)

    • Clarify lysate by centrifugation (14,000g, 15 minutes, 4°C)

  • Pre-clearing step: Incubate lysate with Protein A/G beads for 1 hour at 4°C with rotation

  • Immunoprecipitation:

    • Add 2-5μg of YFR032C-B antibody to pre-cleared lysate

    • Incubate overnight at 4°C with gentle rotation

    • Add fresh Protein A/G beads and incubate for 2 hours at 4°C

  • Wash procedure: Perform 4-5 washes with wash buffer (lysis buffer with 0.1% NP-40)

  • Elution options:

    • Denaturing elution: Boil beads in SDS sample buffer for 5 minutes

    • Native elution: Use excess epitope peptide or low pH glycine buffer (0.1M, pH 2.5)

For reliable interpretation, always include both input controls (typically 5-10% of starting material) and IgG isotype controls to distinguish specific from non-specific interactions .

How should I modify the immunoprecipitation protocol when working with phosphorylated forms of YFR032C-B?

When studying phosphorylated forms of YFR032C-B, several critical modifications to the standard immunoprecipitation protocol are necessary:

  • Phosphatase inhibitors: Add phosphatase inhibitor cocktail containing sodium fluoride (50mM), sodium orthovanadate (1mM), and β-glycerophosphate (10mM) to all buffers

  • Temperature control: Maintain strict temperature control at 4°C throughout all steps

  • Detergent considerations: Use lower concentrations of non-ionic detergents (0.1-0.3% NP-40) to preserve phosphoprotein integrity

  • Antibody selection: Consider using phospho-specific antibodies if studying specific phosphorylation sites on YFR032C-B

  • Validation approach: Include controls treated with lambda phosphatase to confirm phosphorylation-dependent interactions

These modifications are essential because phosphorylation states of YFR032C-B may significantly influence its interaction partners. Following immunoprecipitation, phosphorylation status can be verified using phospho-specific antibodies or mass spectrometry analysis of the immunoprecipitated material.

What controls are essential for properly interpreting YFR032C-B co-immunoprecipitation results?

Proper interpretation of YFR032C-B co-immunoprecipitation requires multiple controls:

  • Input control: Analyze 5-10% of the pre-immunoprecipitation lysate to confirm presence of both YFR032C-B and potential interacting proteins

  • Isotype control: Perform parallel immunoprecipitation with non-specific IgG of the same species and isotype as the YFR032C-B antibody to identify non-specific binding

  • Negative genetic control: Include lysate from yfr032c-bΔ deletion strain to confirm antibody specificity

  • Reverse co-IP: Confirm interactions by performing the reciprocal experiment using antibodies against the putative interacting protein

  • Competition control: Include experiments with excess antigenic peptide to demonstrate binding specificity

Results should be interpreted according to the following principles:

  • True interactions should show enrichment in the YFR032C-B IP lane compared to the IgG control lane

  • The target protein must be present in the input sample

  • Signal intensity in the IgG control lane indicates level of non-specific binding

  • Absence of signal in genetic deletion controls confirms specificity

How can I differentiate between direct and indirect interactions with YFR032C-B protein?

Distinguishing between direct and indirect interactions with YFR032C-B requires multiple complementary approaches:

  • In vitro binding assays: Use purified recombinant YFR032C-B protein and putative interacting proteins in pull-down assays to test direct binding without cellular cofactors

  • Proximity labeling techniques: Employ BioID or APEX2 fusions with YFR032C-B to identify proteins in close proximity (direct interactors) versus those more distant (indirect interactors)

  • Deletion mapping: Create truncated versions of YFR032C-B to identify specific domains required for protein interactions

  • Cross-linking mass spectrometry: Use chemical cross-linkers of defined length followed by mass spectrometry to identify proteins directly bound to YFR032C-B

  • Two-hybrid systems: Employ yeast or bacterial two-hybrid systems as orthogonal methods to validate direct interactions

Results from these approaches should be compiled in a comprehensive interaction map, categorizing proteins as "direct interactors" (confirmed by multiple direct binding assays) or "indirect/complex components" (found only in native co-IP but not in direct binding assays).

What methods can detect post-translational modifications of YFR032C-B and their impact on protein interactions?

To detect post-translational modifications (PTMs) of YFR032C-B and analyze their effects on interactions:

  • Mass spectrometry approaches:

    • Immunoprecipitate YFR032C-B under native conditions

    • Perform tryptic digestion followed by LC-MS/MS analysis

    • Use neutral loss scanning to detect phosphorylation

    • Employ specific fragmentation techniques for different modification types

  • Modification-specific antibodies:

    • Use commercially available anti-phospho, anti-ubiquitin, or anti-SUMO antibodies

    • Develop modification-specific antibodies for YFR032C-B if commonly modified

  • Mobility shift assays:

    • Compare migration patterns on Phos-tag gels for phosphorylation

    • Use SUMO/Ubiquitin-specific proteases to confirm these modifications

  • Functional analysis:

    • Create mutation constructs at identified modification sites

    • Compare interaction profiles between wild-type and mutant proteins

Results should be organized in a data table showing the identified modification sites, the techniques used to detect them, and their impact on specific protein interactions:

ModificationPositionDetection MethodEffect on InteractionsInteracting Partners Affected
PhosphorylationS123LC-MS/MSEnhancedProtein X, Protein Y
UbiquitinationK456Anti-Ub WBReducedProtein Z

This systematic approach allows researchers to correlate specific modifications with changes in the YFR032C-B interactome.

How can I validate YFR032C-B interactions identified in co-immunoprecipitation using orthogonal methods?

Validation of YFR032C-B interactions should employ multiple orthogonal techniques:

  • Reverse co-immunoprecipitation:

    • Immunoprecipitate the potential interacting partner

    • Detect YFR032C-B in the precipitate

  • Microscopy-based methods:

    • Perform co-localization studies using fluorescently tagged proteins

    • Use Förster Resonance Energy Transfer (FRET) to detect proximity in living cells

    • Apply Proximity Ligation Assay (PLA) for in situ detection of interactions

  • Reconstitution assays:

    • Split-YFP or luciferase complementation to visualize interactions in vivo

    • Bacterial two-hybrid or yeast two-hybrid assays

  • Functional assays:

    • Genetic epistasis analysis between YFR032C-B and interactor genes

    • Phenotypic analysis of interaction-deficient mutants

A comprehensive validation approach requires at least three independent methods showing consistent results. Each technique has distinct strengths and limitations, so combining approaches provides the most robust validation.

How should I analyze contradictory results between different antibody lots when studying YFR032C-B?

When faced with contradictory results between different YFR032C-B antibody lots:

  • Antibody characterization:

    • Perform side-by-side Western blots comparing antibody lots against the same samples

    • Test reactivity against recombinant YFR032C-B protein

    • Evaluate epitope mapping data for each antibody lot

  • Validation experiments:

    • Use genetic controls (yfr032c-bΔ strains) with each antibody lot

    • Test each lot in immunoprecipitation followed by mass spectrometry

    • Assess specificity through peptide competition assays

  • Reconciliation approach:

    • Document batch differences systematically

    • Focus on consistently observed interactions across multiple lots

    • Report discrepancies transparently in publications

  • Alternative strategy:

    • Consider using epitope-tagged YFR032C-B for consistency

    • Employ multiple antibodies targeting different epitopes

Contradictory results should be approached as an opportunity to understand the binding characteristics of different antibodies and potentially uncover condition-dependent interactions or modified forms of the protein that may be recognized differently by various antibody preparations.

What bioinformatic analyses can enhance interpretation of YFR032C-B interaction datasets?

Bioinformatic analyses to enhance YFR032C-B interaction data interpretation include:

  • Interaction network analysis:

    • Construct protein-protein interaction networks using tools like Cytoscape

    • Identify interaction clusters and hub proteins

    • Calculate network parameters (centrality, betweenness)

  • Functional enrichment analysis:

    • Apply Gene Ontology (GO) term enrichment to identify biological processes

    • Analyze pathway enrichment using KEGG or Reactome databases

    • Identify protein domain enrichment among interacting partners

  • Evolutionary conservation:

    • Compare interactions across species using ortholog information

    • Identify conserved interaction motifs

  • Integration with other datasets:

    • Correlate interaction data with transcriptomic profiles

    • Incorporate genetic interaction data

    • Map interactions to structural information when available

Results should be visualized through comprehensive network diagrams highlighting functional clusters and key interaction nodes. Statistical significance should be reported for all enrichment analyses (p-values and false discovery rates).

How can I design follow-up experiments to characterize newly identified YFR032C-B interacting proteins?

When characterizing newly identified YFR032C-B interacting proteins, design follow-up experiments using this systematic approach:

  • Interaction confirmation steps:

    • Perform reciprocal co-immunoprecipitation

    • Test interaction under different growth conditions

    • Map the domains/regions required for interaction

  • Functional relationship assessment:

    • Create single and double deletion strains (Δyfr032c-b and Δinteractor)

    • Analyze phenotypes for genetic interactions (synthetic lethality/sickness)

    • Test effects of overexpression of either partner

  • Mechanistic studies:

    • Determine if the interaction affects YFR032C-B stability or localization

    • Assess if the interaction modulates enzymatic activities

    • Investigate effects on known YFR032C-B functions

  • Physiological relevance:

    • Examine interaction under stress conditions

    • Test cell cycle dependence

    • Investigate conservation across species

Prioritize interactors based on strength of evidence, novelty, and connection to known YFR032C-B functions. Design experiments to test specific hypotheses about each interaction rather than using a generic approach for all identified partners.

How can ChIP-Seq experiments with YFR032C-B antibodies be optimized for studying retrotransposon binding sites?

Optimizing ChIP-Seq for YFR032C-B requires specific considerations:

  • Crosslinking optimization:

    • Test multiple formaldehyde concentrations (0.5-3%)

    • Evaluate dual crosslinking with DSG followed by formaldehyde

    • Optimize crosslinking time (10-30 minutes)

  • Chromatin preparation:

    • Compare sonication and enzymatic digestion methods

    • Aim for chromatin fragments of 150-300bp

    • Verify fragment size by agarose gel electrophoresis

  • Immunoprecipitation conditions:

    • Use higher antibody amounts (5-10μg per reaction)

    • Extend incubation time to 16 hours at 4°C

    • Include spike-in controls for normalization

  • Controls and validation:

    • Use input chromatin as control

    • Include IgG mock IP as negative control

    • Validate enrichment at known binding sites by qPCR before sequencing

  • Bioinformatic analysis:

    • Employ specialized peak calling algorithms for repetitive regions

    • Use unique mapping strategies for retrotransposon sequences

    • Perform motif discovery analysis

This optimized protocol addresses the challenges of studying DNA-protein interactions involving retrotransposon elements, which often contain repetitive sequences that can complicate data analysis.

What approaches can improve detection sensitivity when YFR032C-B is expressed at low levels?

Improving detection sensitivity for low-abundance YFR032C-B requires:

  • Sample enrichment methods:

    • Scale up starting material (increase culture volume)

    • Use subcellular fractionation to concentrate relevant compartments

    • Apply protein precipitation methods (TCA or acetone)

  • Signal amplification techniques:

    • Utilize enhanced chemiluminescence (ECL) substrates with higher sensitivity

    • Implement tyramide signal amplification for immunofluorescence

    • Consider biotin-streptavidin based detection systems

  • Instrument optimization:

    • Use highly sensitive digital imaging systems with cooled CCDs

    • Extend exposure times with anti-fade reagents for microscopy

    • Optimize scanner settings for Western blot detection

  • Alternative detection methods:

    • Consider proximity ligation assay (PLA) for in situ detection

    • Use mass spectrometry with targeted acquisition methods (MRM/PRM)

    • Apply digital PCR for transcript quantification

A combination of these approaches can achieve detection limits in the sub-nanogram range, enabling the study of YFR032C-B even under conditions where its expression is significantly downregulated.

How can I adapt immunoprecipitation protocols for studying YFR032C-B in different yeast species or strains?

Adapting immunoprecipitation protocols across yeast species requires systematic optimization:

  • Cell wall disruption:

    • Adjust mechanical disruption parameters based on cell wall thickness

    • Consider species-specific enzymatic treatments (e.g., zymolyase, lyticase)

    • Optimize bead beating cycles based on species resistance

  • Buffer optimization:

    • Test pH ranges (6.8-8.0) for optimal epitope accessibility

    • Adjust ionic strength (100-300mM NaCl) based on species

    • Modify detergent type and concentration for different membrane compositions

  • Antibody considerations:

    • Verify epitope conservation across species

    • Test antibody cross-reactivity with recombinant proteins

    • Consider generating species-specific antibodies if necessary

  • Protocol adjustments:

    • Extend pre-clearing time for species with higher non-specific binding

    • Modify incubation times based on protein expression levels

    • Adapt wash stringency according to antibody cross-reactivity

When working with multiple species, create a standardized protocol with species-specific modifications clearly documented. Perform pilot experiments with each new species to identify the optimal conditions before proceeding with full-scale experiments.

How can single-cell approaches be combined with YFR032C-B antibodies to study cell-to-cell variability?

Combining single-cell approaches with YFR032C-B antibody techniques enables examination of cell-to-cell variability:

  • Flow cytometry applications:

    • Develop intracellular staining protocols for fixed yeast cells

    • Use fluorophore-conjugated YFR032C-B antibodies

    • Apply phospho-specific antibodies to track modification status

    • Combine with cell cycle markers for correlation studies

  • Single-cell imaging:

    • Implement immunofluorescence with high-resolution microscopy

    • Use microfluidic devices for time-lapse imaging of fixed cells

    • Quantify localization patterns at the single-cell level

  • Single-cell proteomics:

    • Apply antibody-based proximity labeling in single cells

    • Combine with mass cytometry (CyTOF) using metal-tagged antibodies

    • Integrate with single-cell transcriptomics for multi-omics analysis

  • Data analysis approaches:

    • Apply machine learning algorithms to classify cell populations

    • Perform trajectory inference to identify cellular states

    • Use Bayesian methods to model protein expression heterogeneity

These approaches allow researchers to move beyond population averages and understand how YFR032C-B expression, localization, and interactions vary between individual cells, providing insights into cellular heterogeneity and its functional consequences.

What are the best practices for studying the dynamics of YFR032C-B interactions using temporal immunoprecipitation?

To study YFR032C-B interaction dynamics using temporal immunoprecipitation:

  • Experimental design:

    • Establish synchronized cell populations (α-factor arrest, elutriation)

    • Collect samples at defined time points (typically 5-10 min intervals)

    • Process all samples simultaneously using identical conditions

  • Technical considerations:

    • Use rapid crosslinking to capture transient interactions

    • Employ a standardized protocol to minimize technical variability

    • Include internal standards for normalization across time points

  • Quantitative analysis:

    • Implement spike-in controls for absolute quantification

    • Use label-free or isotope labeling (SILAC) approaches for mass spectrometry

    • Develop mathematical models to describe interaction kinetics

  • Validation approaches:

    • Confirm key temporal interactions with orthogonal methods

    • Use live-cell imaging with fluorescently tagged proteins

    • Correlate with functional assays at matching time points

Data visualization should include heat maps showing intensity changes over time and interaction networks with temporal information encoded as edge properties. Mathematical modeling can further extract kinetic parameters that describe the assembly and disassembly rates of protein complexes involving YFR032C-B.

How can multi-omics approaches incorporate YFR032C-B antibody-based techniques to provide comprehensive insights?

Integrating YFR032C-B antibody techniques into multi-omics approaches:

  • Integrated workflow design:

    • Develop parallel sample processing from the same cell population

    • Coordinate timing of antibody-based experiments with omics sampling

    • Create standardized lysis procedures compatible with multiple analyses

  • Combined techniques:

    • Chromatin immunoprecipitation followed by sequencing (ChIP-seq) for DNA binding

    • RNA immunoprecipitation (RIP-seq) for associated transcripts

    • Immunoprecipitation followed by mass spectrometry (IP-MS) for protein interactions

    • Proximity labeling (BioID/APEX) for spatial proteomics

  • Data integration strategies:

    • Develop computational pipelines to merge multi-omics datasets

    • Apply network analysis to identify regulatory relationships

    • Use machine learning for predictive modeling across data types

  • Visualization and interpretation:

    • Create multi-layer network visualizations

    • Develop circular plots showing relationships across omics layers

    • Implement interactive dashboards for data exploration

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.